Breast Cancer
‘Like’ it or not: The dos and don’ts of social media for oncologists
Just as physicians became accustomed to wearing pagers 40 years ago or being tied to smartphones 2 decades ago, many have become active on social media as it entered their practices.
FDA approves Lynparza for new breast cancer indication
The FDA expanded the approval of olaparib to include a new breast cancer indication.
Trodelvy prolongs PFS in metastatic breast cancer subset, topline data show
A phase 3 study of sacituzumab govitecan-hziy met its primary endpoint of PFS among a subset of patients with hormone receptor-positive, HER2-negative metastatic breast cancer, according to topline data released by the agent’s manufacturer.
Daily remote outcome assessments may improve symptom management during cancer treatment
Daily electronic patient-reported outcome assessments may provide valuable insight into symptom management among patients with cancer undergoing antineoplastic treatment, according to a study published in JAMA Network Open.
Depression screening may improve care after breast cancer diagnosis
Tailored strategies for implementation of routine depression screening increased the proportion of patients with breast cancer referred to behavioral care, according to study results.
Personalized cell therapy shows promise in metastatic breast cancer
Three of six women with metastatic breast cancer who received investigational tumor-infiltrating lymphocytes plus pembrolizumab demonstrated tumor reductions greater than 50%, according to phase 2 study results.
BRCA mutations linked to increased risk for pancreatic, male breast, other cancers
Pathogenic variants in BRCA1 and BRCA2 appeared associated with increased risks for prostate cancer, pancreatic cancer, male breast cancer and possibly stomach cancer, according to research published in Journal of Clinical Oncology.
Low or no meat diet may reduce risk for breast, colorectal, prostate cancer
Eating meat five times or less per week was linked to a lower overall risk for cancer, according to observational findings published in BMC Medicine.
Breast cancer overdiagnosis rate ‘not as alarmingly high’ as reported among certain women
An estimated 1 in 7 screen-detected breast cancers in biennially screened women aged 50 to 74 years will be overdiagnosed, according to an analysis of an authoritative U.S. population data set published in Annals of Internal Medicine.
Breast cancer specialist named director of Vanderbilt-Ingram Cancer Center
Ben Ho Park, MD, PhD, has been appointed director of Vanderbilt-Ingram Cancer Center.